Age, But Not Repeated Exposure to Gadoterate Meglumine, Is Associated With T1- and T2-Weighted Signal Intensity Changes in the Deep Brain Nuclei of Pediatric Patients.
Sign Up to like & getrecommendations! Published in 2019 at "Investigative Radiology"
DOI: 10.1097/rli.0000000000000564
Abstract: OBJECTIVES Current findings on gadolinium deposition in the pediatric brain due to repeated exposure to macrocyclic contrast agents are inconclusive and possibly confounded by brain maturation processes. We evaluated the longitudinal effects of repeated gadoterate… read more here.
Keywords: gadoterate meglumine; age; repeated exposure; brain ... See more keywords
Safety of gadoterate meglumine in over 1600 children included in the prospective observational SECURE study.
Sign Up to like & getrecommendations! Published in 2019 at "Acta radiologica"
DOI: 10.1177/0284185119840649
Abstract: BACKGROUND To date, few data on the safety profile of gadoterate meglumine in pediatric patients are available. PURPOSE To assess the safety profile of gadoterate meglumine in routine practice, to detect any case of nephrogenic… read more here.
Keywords: observational secure; safety; study; gadoterate meglumine ... See more keywords